Plunkett Research Online: Hemostemix

HEMOSTEMIX (HEM) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The .....


HEMOSTEMIX

Ticker: HEM
Exchange: TSXV
Parent Company:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 4th Street South West
Calgary, AB T2R 1J4 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Thomas SmeenkCEO/Co-Founder/Director/President
Christina WuCFO
See More
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture